Roles and Interaction of the MAPK Signaling Cascade in Aβ25–35-Induced Neurotoxicity Using an Isolated Primary Hippocampal Cell Culture System
- 29 June 2020
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 41 (7) , 1497-1507
Abstract
Alzheimer's disease (AD) is characterized with increased formation of amyloid-β (Aβ) in the brain. Aβ peptide toxicity is associated with disturbances of several intracellular signaling pathways such as mitogen activated protein kinases (MAPKs). The aim of this study was to investigate the role of MAPKs and their interactions in Aβ-induced neurotoxicity using isolated hippocampal neurons from the rat. Primary hippocampal cells were cultured in neurobasal medium for 4 days. Cells were treated with Aβ25–35 and/or MAPKs inhibitors for 24 h. Cell viability was determined by an MTT assay and phosphorylated levels of P38, JNK, and ERK were measured by Western blots. Aβ treatment (10–40 µM) significantly decreased hippocampal cell viability in a dose-dependent manner. Inhibition of P38 and ERK did not restore cell viability, while JNK inhibition potentiated the Aβ-induced neurotoxicity. Compared to the controls, Aβ treatment increased levels of phosphorylated JNK, ERK, and c-Jun, while it had no effect on levels of phosphorylated P38. In addition, P38 inhibition led to decreased expression levels of phosphorylated ERK; inhibition of JNK resulted in decreased expression of c-Jun; and inhibition of ERK, decreased phosphorylated levels of JNK. These results strongly suggest that P38, ERK, and JNK are not independently involved in Aβ-induced toxicity in the hippocampal cells. In AD, which is a multifactorial disease, inhibiting a single member of the MAPK signaling pathway, does not seem to be sufficient to mitigate Aβ-induced toxicity and thus their interactions with each other or potentially with different signaling pathways should be taken into account.Keywords
Funding Information
- National Institute for Medical Research Development (958343)
This publication has 58 references indexed in Scilit:
- Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2012
- The Role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative DiseaseJournal of Signal Transduction, 2012
- Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFαMolecular Neurodegeneration, 2011
- Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)Journal of Neuroinflammation, 2011
- c-Jun N-terminal Kinase (JNK-1) Confers Protection against Brief but Not Extended Ischemia during Acute Myocardial InfarctionJournal of Biological Chemistry, 2011
- Regulation of the severity of neuroinflammation and demyelination by TLR‐ASK1‐p38 pathwayEMBO Molecular Medicine, 2010
- MAPK signalling in cellular metabolism: stress or wellness?EMBO Reports, 2010
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial ActivationThe Journal of Neuroscience, 2009
- JNK protects Drosophila from oxidative stress by trancriptionally activating autophagyMechanisms of Development, 2009
- Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's diseaseJournal of Neuroinflammation, 2008